Research indicates that goflikicept may modulate immune responses in patients with idiopathic recurrent pericarditis, as revealed by single-cell RNA profiling. This study could pave the way for new therapeutic strategies in managing this condition.
single cell rna profiling suggests goflikicept mediated immune modulation in idiopathic recurrent pericarditis
Original title: “Single-cell RNA profiling suggests goflikicept-mediated immune modulation in idiopathic recurrent pericarditis.”